What Is Tesamorelin?

Tesamorelin, commonly known as Egrifta (its FDA-approved brand name), is a synthetic peptide designed to mimic the body’s natural growth hormone–releasing hormone (GHRH). In simple terms, it works by signaling the pituitary gland to increase growth hormone production, which can influence metabolism, body fat levels, and overall wellness.

Originally developed and approved for the treatment of HIV-associated lipodystrophy—a condition characterized by persistent abdominal fat—Tesamorelin has since gained attention in broader research settings. It is particularly noted for its effects on visceral fat, the deeper fat stored around internal organs that is closely linked to increased health risks.

Who might need it?

Tesamorelin is currently being explored for its potential benefits in individuals who:

Struggle with stubborn belly fat that does not respond easily to diet or exercise
Want to support better metabolism and overall health
Are aiming to increase energy levels and improve how they feel with age

Common signs associated with these concerns include persistent abdominal fat, low energy levels, and slower recovery.

This article will guide you through what Tesamorelin does, how it works within the body, the benefits highlighted in research, and important considerations such as dosage and possible side effects. It will also compare Tesamorelin with other popular peptides to help you understand what makes it unique.

Key Benefits of Tesamorelin

Tesamorelin is not a “do-it-all” peptide, but its benefits are well-defined in research, particularly in areas such as fat metabolism, hormone balance, and overall wellness support. Here’s where it stands out the most…

Visceral Fat Reduction and Body Composition
If you’ve ever dealt with stubborn fat that refuses to go away—especially deep abdominal fat—you understand how challenging it can be. Tesamorelin is one of the few peptides backed by strong clinical data showing its ability to reduce visceral adipose tissue (VAT).

The Link Between Deep Belly Fat and Chronic Illness
Deep belly fat is more than a cosmetic concern, as it surrounds vital organs and contributes to serious health conditions, which is why reducing it is important.

Below are some of the key health risks associated with excess visceral fat:

• Raises the risk of heart disease and stroke
• Increases the likelihood of type 2 diabetes and insulin resistance
• Contributes to fatty liver and worsened liver enzyme levels
• Drives chronic inflammation and metabolic syndrome

Reducing visceral fat may help lower these risks and support better long-term health, which is what makes Tesamorelin’s effects clinically significant.

In clinical studies, Tesamorelin has been shown to reduce visceral fat by approximately 10 to 18 percent within 3 to 6 months, while preserving lean muscle mass—unlike strict calorie-restricted diets that often lead to both fat and muscle loss.

To simplify, Tesamorelin may support:

• Targeted reduction of abdominal fat
• Improved waist-to-hip ratio and overall body composition
• Preservation of lean muscle during fat loss

This combination of reducing harmful fat while maintaining muscle is what makes Tesamorelin a standout option in research focused on body composition improvement.